DDAVP

In some countries, this medicine may only be approved for veterinary use.

In the US, DDAVP (desmopressin systemic) is a member of the drug class antidiuretic hormones and is used to treat Diabetes Insipidus, Hemophilia A, Primary Nocturnal Enuresis and von Willebrand's Disease.

US matches:

• DDAVP


• DDAVP Solution


• DDAVP Spray (Non-refrigerated)


• DDAVP Tube


• DDAVP Rhinal Tube nasal


• DDAVP injection


• DDAVP nasal


• DDAVP Rhinal Tube


• DDAVP Nasal Spray


• DDAVP Tablets

UK matches:

• DDAVP/Desmopressin Injection
• DDAVP Melt 60mcg, 120mcg and 240mcg oral lyophilisate (SPC)
• DDAVP Tablets 0.1mg (SPC)
• DDAVP Tablets 0.2mg (SPC)
• DDAVP/Desmopressin Injection (SPC)
• DDAVP/Desmopressin Intranasal Solution (SPC)

Ingredient matches for DDAVP

Desmopressin

Desmopressin is reported as an ingredient of DDAVP in the following countries:

• Greece


• Portugal

Desmopressin acetate (a derivative of Desmopressin) is reported as an ingredient of DDAVP in the following countries:

• Canada


• Chile


• South Africa


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.